 08-Jan-19, MedTech Intelligence 

As Asia’s prostate cancer burden grows, so do opportunities for Western medical device companies with products to diagnose and treat the disease. Leading Western medical device firms are moving into markets across the Asian region to promote their most innovative products.

Image: MedTech Intelligence

Historically, rates of prostate cancer have been low in Asia compared with rates in North America, Europe and Australia. But a rapidly aging population, economic growth and rising industrialization is driving a steep increase in diagnosis of the disease and Asian countries are playing catch up when it comes to detection, treatment and survival.

Treatment for prostate cancer is driving demand for better and more innovative medical technology. In Asia, economic development over the past two decades has fueled earlier diagnoses, increased access to medications, and sophisticated radiation and surgical techniques. The most significant inroads have been made by medical device firms specializing in external radiation therapy, internal radiation therapy and laparoscopic robotic surgery.

 Read the full article  

 Healthcare insights